Marshall Ken W. - Insider Non-Derivative Transactions at Aquestive Therapeutics, Inc. (AQST) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 9, 2023, Marshall Ken W.'s relationship to Aquestive Therapeutics, Inc. (AQST) is Officer (SVP, Chief Commercial Officer), and currently has 150,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other AQST insiders.
Data Source: SEC.
Marshall Ken W. - Insider Non-Derivative Transactions at AQST
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 10, 2023 | Acquisition -- (Common Stock) | 150000 | 0 | 150000 |